Danielle Watson - 14 Jun 2022 Form 3 Insider Report for Heart Test Laboratories, Inc. (HSCS)

Role
Vice President and Chief Financial Officer
Signature
/s/ Danielle Watson
Issuer symbol
HSCS
Transactions as of
14 Jun 2022
Transactions value $
$0
Form type
3
Filing time
06 Jul 2022, 13:31:37 UTC
Next filing
22 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HSCS Employee Stock Option (Right to Buy) 14 Jun 2022 Common Stock 4.55K $3.47 Direct F1
holding HSCS Employee Stock Option (Right to Buy) 14 Jun 2022 Common Stock 4.55K $3.47 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option becomes exercisable in multiple installments upon the passing of certain periods. The first installment of approximately 33% of the option vests and becomes exercisable on October 31, 2022, and the remainder vests and becomes exercisable in equal instalments over the following eight fiscal quarters.
F2 The entire option has become fully-vested and may be exercised at any time at the Holder's election.

Remarks:

Vice President and Chief Financial Officer